In tumor cells, IL-6 enriched EVsMMA-MRC5 activates IL-6/JAK/STAT3 and TGFβ signaling, promoting EMT and the acquisition of pro-aggressive traits (Fig. 6). The gene discussed is STAT3; the disease is neoplasm.